Halaven
- Product NDC
- 62856-389
- 11-digit product format
- 628560389
- Labeler code
- 62856
- Product ID
- 62856-389_2c75a415-0b1e-4c36-8301-c50ac155d980
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- eribulin mesylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Eisai Inc.
- Application
- NDA201532
- Marketing category
- NDA
- Marketing start
- 2010-11-15
- Substance
- ERIBULIN MESYLATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Halaven
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERIBULIN MESYLATE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | AV9U0660CW |
| Rxcui | 1045456, 1045460 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62856-389-01 | Halaven | 1 in 1 CARTON | INJECTION | 1 | | 69 |
| 62856-389-01 | Halaven | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | | 69 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62856-389 | HALAVEN (ERIBULIN MESYLATE) INJECTION [EISAI INC.] | 68 | Current NDC, Legacy NDC, 2 package rows | 20241120_31ce4750-ded5-4a0b-95e9-f229fa6bc822.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62856-389-01 | 62856038901 | 1 VIAL, SINGLE-DOSE in 1 CARTON (62856-389-01) / 2 mL in 1 VIAL, SINGLE-DOSE | 2010-11-15 | 0000-00-00 | No | No | Current |